IWM
EDIT icon

IHT Wealth Management’s Editas Medicine EDIT Stock Holding History

IHT Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,953
Closed -$90.1K – 977
2023
Q2 		$90.1K Sell
10,953
-1,386
-11% -$12.1K ﹤0.01% 931
2023
Q1 		$89.5K Sell
12,339
-238
-2% -$2.12K 0.01% 908
2022
Q4 		$112K Sell
12,577
-881
-7% -$9.67K 0.01% 857
2022
Q3 		$165K Buy
+13,458
New +$210K 0.01% 795
2021
Q4 		– Sell
-6,626
Closed -$272K – 822
2021
Q3 		$272K Sell
6,626
-3,934
-37% -$216K 0.02% 629
2021
Q2 		$598K Buy
10,560
+1,458
+16% +$53.9K 0.04% 469
2021
Q1 		$382K Buy
9,102
+892
+11% +$50.8K 0.03% 549
2020
Q4 		$576K Buy
+8,210
New +$337K 0.05% 361
2018
Q2 		– Sell
-204
Closed -$6K – 671
2018
Q1 		$6K Buy
204
+74
+57% +$2.64K ﹤0.01% 1297
2017
Q4 		$4K Buy
130
+18
+16% +$453 ﹤0.01% 1377
2017
Q3 		$3K Buy
112
+42
+60% +$799 ﹤0.01% 1152
2017
Q2 		$107 Buy
+70
New +$1.26K 0.05% 326

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IHT Wealth Management's EDIT Position: Q3 2023 in Review

IHT Wealth Management sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 10,953 shares — an estimated $90.1K sold.

IHT Wealth Management first reported a position in EDIT in Q2 2017 and held it in 12 quarters. The position peaked at $598K in Q2 2021. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • IHT Wealth Management reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • IHT Wealth Management sold 10,953 Editas Medicine shares in Q3 2023, an estimated $90.1K.
  • IHT Wealth Management first reported a position in Editas Medicine in Q2 2017 and held it in 12 quarters.
  • IHT Wealth Management's Editas Medicine position peaked at $598K in Q2 2021.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on IHT Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.